Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications (2018)
- Authors:
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- DOI: 10.1093/neuonc/nox183
- Subjects: GLIOMA; METILAÇÃO DE DNA; MUTAÇÃO GENÉTICA; GENOMAS
- Keywords: CgP island methylator phenotype (CIMP); DNA methylation; G-CIMP (glioma-CIMP); Glioma progression; IDH mutation; Molecular subtypes
- Agências de fomento:
- Financiado pelo Henry Ford Hospital
- Financiado pelo Henry Ford Hospital
- Financiado pelo Henry Ford Hospital
- Financiado pelo Henry Ford Hospital
- Financiado pelo Henry Ford Hospital
- Financiado pelo Henry Ford Hospital
- Financiado pelo Henry Ford Hospital
- Financiado pelo Henry Ford Hospital
- Financiado pelo Henry Ford Hospital
- Financiado pela FAPESP
- Financiado pela FAPESP
- Financiado pela CAPES
- Financiado pelo CNPq
- Language: Inglês
- Imprenta:
- Source:
- Título: Neuro-Oncology
- ISSN: 1522-8517
- Volume/Número/Paginação/Ano: v. 20, n. 5, p. 608-620, 2018
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
MALTA, Tathiane M. et al. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. Neuro-Oncology, v. 20, n. 5, p. 608-620, 2018Tradução . . Disponível em: https://doi.org/10.1093/neuonc/nox183. Acesso em: 19 jan. 2026. -
APA
Malta, T. M., Souza, C. F. de, Sabedot, T. S., Silva, T. C., Mosella, M. S., Kalkanis, S. N., et al. (2018). Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. Neuro-Oncology, 20( 5), 608-620. doi:10.1093/neuonc/nox183 -
NLM
Malta TM, Souza CF de, Sabedot TS, Silva TC, Mosella MS, Kalkanis SN, Snyder J, Castro AVB, Noushmehr H. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications [Internet]. Neuro-Oncology. 2018 ; 20( 5): 608-620.[citado 2026 jan. 19 ] Available from: https://doi.org/10.1093/neuonc/nox183 -
Vancouver
Malta TM, Souza CF de, Sabedot TS, Silva TC, Mosella MS, Kalkanis SN, Snyder J, Castro AVB, Noushmehr H. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications [Internet]. Neuro-Oncology. 2018 ; 20( 5): 608-620.[citado 2026 jan. 19 ] Available from: https://doi.org/10.1093/neuonc/nox183 - Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication
- Epigenomics analysis of the Cancer Genome Atlas (TCGA) lower-grade gliomas
- USC researchers discover genetic clues that increase understanding of mechanisms involved in prostate cancer predisposition [Depoimento a Lelie Ridgeway]
- The somatic genomic landscape of glioblastoma
- Comprehensive analysis of cancer stemness
- Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning
- DNA sequences differentially associated with Sirt1 and Dnmt3b during melanoma progression
- Imaging and diagnostic advances for intracranial meningiomas
- Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers
- Whole genome DNA is distinctly methylated in functioning and non-functioning pituitary macroadenomas
Informações sobre o DOI: 10.1093/neuonc/nox183 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002950036.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
